Analysis of the Global Sepsis Pipeline, 2024 with Insights on 30+ Companies and 35+ Pipeline Drugs, Including Thymosin Alpha 1 (Sci Clone Pharmaceuticals) and Enibarcimab (AdrenoMed)
31. Mai 2024 06:18 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
Sepsis Drug Pipeline Research Report 2022: Comprehensive Insights about 40+ Companies and 40+ Pipeline Drugs
15. Dezember 2022 08:13 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...
2021 Sepsis Pipeline Insight with 40+ Companies and 40+ Pipeline Durgs
05. März 2021 04:13 ET
|
Research and Markets
Dublin, March 05, 2021 (GLOBE NEWSWIRE) -- The "Sepsis Pipeline Insight 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. This report provides comprehensive insights about...